EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Genus's Enterprise Value is €1,689.2 Mil.
Genus's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was €11.7 Mil. Therefore, Genus's EV-to-FCF for today is 144.45.
The historical rank and industry rank for Genus's EV-to-FCF or its related term are showing as below:
FRA:GBE'
s EV-to-FCF Range Over the Past 10 Years
Min: -75.06 Med: 78.87 Max: 477.4
Current: 139.64
During the past 13 years, the highest EV-to-FCF of Genus was 477.40. The lowest was -75.06. And the median was 78.87.
FRA:GBE's EV-to-FCF is ranked worse than 90.84% of 393
companies
in the Biotechnology industry
Industry Median: 4.47
vs FRA:GBE: 139.64
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-05-01), Genus's stock price is €20.20.
Genus's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €0.589. Therefore, Genus's PE Ratio for today is 34.30.
Genus EV-to-FCF Historical Data
The historical data trend for Genus's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Genus's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genus's EV-to-FCF Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Genus's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Genus's EV-to-FCF falls into.
Genus's current Enterprise Value is €1,689.2 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Genus's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was €11.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genus (FRA:GBE) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Genus's share price for today is €20.20.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Genus's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €0.589.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Genus EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Genus's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Genus PLC is a biotechnology company that develops animal genetics for agricultural purposes. The company breeds and distributes the genes of pigs and bulls, scientifically selecting livestock whose offspring are designed to increase the profitability of its customers. In the porcine market, Genus sells boars and sows that produce offspring with desirable characteristics, such as feed-efficient growth or leaner meat. In the dairy and beef markets, the company's primary product is bull semen, which is delivered through artificial insemination to improve its customers' herds and their efficiency. Genus also offers embryos through its subsidiary IVB.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:GBE has been successfully added to your 